Figure 1. Odds ratios and 95% CIs for venous thromboembolism per soluble urokinase plasminogen activator receptor (suPAR) tertile in patients hospitalized with COVID‐19, with and without adjustments for baseline covariables and D‐dimer level.

Baseline clinical characteristics included in model 1: age, sex, Black race, body mass index, history of diabetes, history of hypertension, history of congestive heart failure, history of atrial fibrillation or flutter, history of stroke, history of chronic obstructive pulmonary disease, history of malignancy, before admission anticoagulation therapy, and estimated glomerular filtration rate.